Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Update on current management of chronic kidney disease in patients with HIV infection.

Diana NE, Naicker S.

Int J Nephrol Renovasc Dis. 2016 Sep 16;9:223-234. eCollection 2016. Review.

2.
3.

Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.

Neogi U, Häggblom A, Singh K, Rogers LC, Rao SD, Amogne W, Schülter E, Zazzi M, Arnold E, Sarafianos SG, Sönnerborg A.

J Antimicrob Chemother. 2016 Feb;71(2):367-71. doi: 10.1093/jac/dkv359. Epub 2015 Oct 30.

4.

African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era.

Kasembeli AN, Duarte R, Ramsay M, Naicker S.

World J Nephrol. 2015 May 6;4(2):295-306. doi: 10.5527/wjn.v4.i2.295. Review.

5.

Southern Africa: the Highest Priority Region for HIV Prevention and Care Interventions.

Vermund SH, Sheldon EK, Sidat M.

Curr HIV/AIDS Rep. 2015 Jun;12(2):191-5. doi: 10.1007/s11904-015-0270-z. Erratum in: Curr HIV/AIDS Rep. 2015 Sep;12(3):373.

6.

APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.

Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, Limou S, Sezgin E, Nelson GW, Fogo AB, Goetsch S, Kopp JB, Winkler CA, Naicker S.

J Am Soc Nephrol. 2015 Nov;26(11):2882-90. doi: 10.1681/ASN.2014050469. Epub 2015 Mar 18.

7.

High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.

Gounder K, Padayachi N, Mann JK, Radebe M, Mokgoro M, van der Stok M, Mkhize L, Mncube Z, Jaggernath M, Reddy T, Walker BD, Ndung'u T.

PLoS One. 2015 Mar 17;10(3):e0119886. doi: 10.1371/journal.pone.0119886. eCollection 2015.

8.
9.

Sample size considerations in the design of cluster randomized trials of combination HIV prevention.

Wang R, Goyal R, Lei Q, Essex M, De Gruttola V.

Clin Trials. 2014 Jun;11(3):309-318. doi: 10.1177/1740774514523351.

10.

Sources of HIV incidence among stable couples in sub-Saharan Africa.

Chemaitelly H, Awad SF, Shelton JD, Abu-Raddad LJ.

J Int AIDS Soc. 2014 Feb 21;17:18765. doi: 10.7448/IAS.17.1.18765. eCollection 2014.

11.

HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.

Kahle E, Campbell M, Lingappa J, Donnell D, Celum C, Ondondo R, Mujugira A, Fife K, Mugo N, Kapiga S, Mullins JI, Baeten JM; Partners in Prevention HSVHIV Transmission Study Team.

AIDS. 2014 Jan 14;28(2):235-43. doi: 10.1097/QAD.0000000000000024.

12.

Phylogenetic relatedness of circulating HIV-1C variants in Mochudi, Botswana.

Novitsky V, Bussmann H, Logan A, Moyo S, van Widenfelt E, Okui L, Mmalane M, Baca J, Buck L, Phillips E, Tim D, McLane MF, Lei Q, Wang R, Makhema J, Lockman S, DeGruttola V, Essex M.

PLoS One. 2013 Dec 11;8(12):e80589. doi: 10.1371/journal.pone.0080589. eCollection 2013.

13.

Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.

Mann JK, Byakwaga H, Kuang XT, Le AQ, Brumme CJ, Mwimanzi P, Omarjee S, Martin E, Lee GQ, Baraki B, Danroth R, McCloskey R, Muzoora C, Bangsberg DR, Hunt PW, Goulder PJ, Walker BD, Harrigan PR, Martin JN, Ndung'u T, Brockman MA, Brumme ZL.

Retrovirology. 2013 Sep 16;10:100. doi: 10.1186/1742-4690-10-100.

14.

Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions.

Brenner B, Wainberg MA, Roger M.

AIDS. 2013 Apr 24;27(7):1045-57. doi: 10.1097/QAD.0b013e32835cffd9. Review. No abstract available.

15.

Future of phylogeny in HIV prevention.

Brenner BG, Wainberg MA.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S248-54. doi: 10.1097/QAI.0b013e3182986f96.

16.

Reply to Neogi et al.

Campbell MS, Kahle EM, Baeten JM.

J Infect Dis. 2013 Sep 1;208(5):867-8. doi: 10.1093/infdis/jit259. Epub 2013 Jun 10. No abstract available.

17.

Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.

Fiscus SA, Cu-Uvin S, Eshete AT, Hughes MD, Bao Y, Hosseinipour M, Grinsztejn B, Badal-Faesen S, Dragavon J, Coombs RW, Braun K, Moran L, Hakim J, Flanigan T, Kumarasamy N, Campbell TB; A5185s Team.

Clin Infect Dis. 2013 Jul;57(2):290-7. doi: 10.1093/cid/cit195. Epub 2013 Mar 26.

18.

Intra-host evolutionary rates in HIV-1C env and gag during primary infection.

Novitsky V, Wang R, Rossenkhan R, Moyo S, Essex M.

Infect Genet Evol. 2013 Oct;19:361-8. doi: 10.1016/j.meegid.2013.02.023. Epub 2013 Mar 20.

19.

tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.

Rossenkhan R, MacLeod IJ, Sebunya TK, Castro-Nallar E, McLane MF, Musonda R, Gashe BA, Novitsky V, Essex M.

J Virol. 2013 May;87(10):5732-45. doi: 10.1128/JVI.03297-12. Epub 2013 Mar 13.

20.

Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters.

Campbell MS, Kahle EM, Celum C, Lingappa JR, Kapiga S, Mujugira A, Mugo NR, Fife KH, Mullins JI, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.

J Infect Dis. 2013 Apr;207(7):1166-70. doi: 10.1093/infdis/jit015. Epub 2013 Jan 11.

Supplemental Content

Support Center